The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Growth modulation index and RECIST-based STBSG-EORTC criteria for the assessment of drug activity in advanced soft tissue sarcoma (ASTS) patients (pts).
Sophie Cousin
No relevant relationships to disclose
Jean-Yves Blay
No relevant relationships to disclose
François Bertucci
No relevant relationships to disclose
Nicolas Isambert
No relevant relationships to disclose
Antoine Italiano
No relevant relationships to disclose
Emmanuelle Bompas
No relevant relationships to disclose
Isabelle Ray-Coquard
No relevant relationships to disclose
Delphine Perrot
No relevant relationships to disclose
Binh Bui Nguyen
No relevant relationships to disclose
Marie Chaix
No relevant relationships to disclose
Loic Chaigneau
No relevant relationships to disclose
Nadege Corradini
No relevant relationships to disclose
Nicolas Penel
No relevant relationships to disclose